A BUD on your compounded vial means something different entirely

daily dosing one injection per week requires less daily effort than remembering oral semaglutide with timing restrictions Higher bioavailability injectable semaglutide has approximately 89% absorption compared to roughly less than 1% for oral semaglutide, which can impact consistency and efficacy No empty-stomach requirement more flexible timing throughout your day Customizable dosing our GLP-1 ID program enables provider-guided weekly dose adjustments based on your biology, symptoms, and progress Oral GLP-1s may suit you if you: Have needle aversion or anxiety around injections Travel frequently and prefer no refrigeration requirements Are comfortable with daily dosing on an empty stomach with a 30-minute wait Injectable GLP-1s may suit you if you: Want to maximize weight loss based on current clinical data Prefer once-weekly dosing over daily routines Need flexible timing without empty-stomach requirements Want customizable dosing through our GLP-1 ID program Injectables: side effects may peak after dosing and ease off, allowing gradual adjustment during weekly routines

long-term BPC-157 use carries unquantified risk until prospective human trials establish pharmacokinetics and toxicity thresholds across extended timeframes
Possible side effects are typically mild and temporary, including injection site reactions, occasional headaches, nausea, or lightheadedness, and a metallic taste in the mouth
Superoxide dismutase (SOD) plays a major role in eliminating mitochondrial ROS